Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.33B
| $936M | 0.18% |
34,470,676
+814,198
| +2% | +$21.2M |
|
102
CVS Health
CVS
$133B
| $925M | 0.17% |
13,647,873
+728,924
| +6% | +$43.6M |
|
|
FITB
103
Fifth Third Bancorp
FITB
$52.4B
| $898M | 0.17% |
22,908,401
+1,321,554
| +6% | +$55.7M |
|
104
Gilead Sciences
GILD
$168B
| $898M | 0.17% |
8,010,501
+7,722
| +0.1% | +$797K |
|
105
T-Mobile US
TMUS
$190B
| $879M | 0.16% |
3,295,432
+65,394
| +2% | +$16.1M |
|
106
Union Pacific
UNP
$176B
| $874M | 0.16% |
3,700,195
+37,411
| +1% | +$9.01M |
|
107
Danaher
DHR
$137B
| $867M | 0.16% |
4,230,087
+163,332
| +4% | +$35.7M |
|
108
Boston Scientific
BSX
$71.1B
| $865M | 0.16% |
8,576,214
+101,183
| +1% | +$10.2M |
|
109
Kinder Morgan
KMI
$69.9B
| $855M | 0.16% |
29,980,425
-312,986
| -1% | -$8.67M |
|
110
Hershey
HSY
$36B
| $854M | 0.16% |
4,991,639
+356,249
| +8% | +$58.3M |
|
111
Public Storage
PSA
$61B
| $848M | 0.16% |
2,836,477
+34,718
| +1% | +$10.4M |
|
112
TJX Companies
TJX
$174B
| $848M | 0.16% |
6,960,105
+62,171
| +0.9% | +$7.55M |
|
113
Equinix
EQIX
$104B
| $848M | 0.16% |
1,039,453
-135,509
| -12% | -$122M |
|
114
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.27B
| $847M | 0.16% |
42,219,385
-2,567,694
| -6% | -$51.4M |
|
115
Archer Daniels Midland
ADM
$38.5B
| $838M | 0.16% |
17,455,324
+13,579,379
| +350% | +$657M |
|
116
Vertex Pharmaceuticals
VRTX
$121B
| $836M | 0.16% |
1,725,281
+61,432
| +4% | +$28.6M |
|
117
Honeywell
HON
$78.9B
| $836M | 0.16% |
4,189,419
+50,326
| +1% | +$10.2M |
|
|
FISV
118
Fiserv Inc
FISV
$29.7B
| $833M | 0.16% |
3,771,505
+150,720
| +4% | +$33M |
|
119
Darden Restaurants
DRI
$23.4B
| $831M | 0.16% |
3,998,200
+247,542
| +7% | +$47.8M |
|
120
Starbucks
SBUX
$120B
| $822M | 0.15% |
8,382,948
-496,799
| -6% | -$51.4M |
|
121
Lowe's Companies
LOW
$122B
| $817M | 0.15% |
3,501,740
+42,676
| +1% | +$10.5M |
|
122
Intel
INTC
$509B
| $795M | 0.15% |
35,025,596
+1,086,836
| +3% | +$23.8M |
|
123
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.87B
| $794M | 0.15% |
20,959,358
+1,274,728
| +6% | +$52.3M |
|
124
Elevance Health
ELV
$82B
| $775M | 0.15% |
1,782,653
+109,628
| +7% | +$44M |
|
125
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $764M | 0.14% |
14,159,711
-4,018,492
| -22% | -$216M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.